These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6158179)

  • 1. [Smallpox vaccination with protection by interferon and an interferon inducer].
    Bektemirov TA; Burgasova MP; Kuznetsov VP; Rozina EE; Andzhaparidze OG
    Vopr Virusol; 1980; (1):76-8. PubMed ID: 6158179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined action of a specific vaccine, exogenous interferon and an interferon inducer on the development of acute experimental encephalomyelitis].
    Barinskiĭ IF; Vagabov RM
    Vopr Virusol; 1983; 28(1):62-6. PubMed ID: 6189299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.
    Israely T; Melamed S; Achdout H; Erez N; Politi B; Waner T; Lustig S; Paran N
    PLoS One; 2014; 9(10):e110545. PubMed ID: 25350003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon production by various means of administering modified poly I-C].
    Andzhaparidze OG; Bektemirov TA; Burgasova MP; Ogleznev KIa
    Vopr Virusol; 1981; (4):407-10. PubMed ID: 6171096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of detectable viremia in plasma and peripheral blood mononuclear cells from smallpox vaccinees: implications for blood safety.
    Srinivasan K; Akolkar PN; Taffs RE; Hewlett IK
    Transfusion; 2006 Sep; 46(9):1589-92. PubMed ID: 16965588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of possible use of interferon inductors for prevention of postvaccional reactions to TEOVac in animal models].
    Chernikova NK; Bondareva TA; Borisevich SV; Dorokhina TV; Khmelev AL; Shagarova NV
    Antibiot Khimioter; 2011; 56(9-10):19-22. PubMed ID: 22586899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly I:C/poly-L-lysine: potent inducer of interferons in primates.
    Lampson GP; Field AK; Tytell AA; Hilleman MR
    J Interferon Res; 1981; 1(4):539-49. PubMed ID: 7202031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological efficacy of smallpox vaccination in children with relative contraindications to vaccination].
    Denisov GM; Kossova ET; Rybalko DI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jan; (1):68-72. PubMed ID: 1124611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of human leukocytic interferon in the therapy and prevention of postvaccinal complications following mass vaccination against smallpox].
    Petricvić I; Soldo I; Soos E; Smerdel S; Jusić D; Kunsten D
    Lijec Vjesn; 1974 Jun; 96(6):349-54. PubMed ID: 4461877
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon tolerance and antiviral protection in mice given single or multiple injections of endotoxin or poly I : C.
    Giron DJ; Schmidt JP; Pindak FF; Connell JE
    Acta Virol; 1973 May; 17(3):209-14. PubMed ID: 4147139
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical picture of postvaccinal reactions in children vaccinated against smallpox by the 2-stage method].
    Shulgaia IG
    Pediatr Akus Ginekol; 1976; (6):23-4. PubMed ID: 1025509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of poly I-C complex with poly-L lysine on smallpox vaccine keratitis in monkeys].
    Andzhaparidze OG; Bektemirov TA; Burgasova MP
    Vopr Virusol; 1978; (1):116-8. PubMed ID: 417471
    [No Abstract]   [Full Text] [Related]  

  • 14. [The comparative study of the safety of a vaccinal process in both oral and epicutaneous immunization against smallpox].
    Bektimirov TA; Podkuĭko VN; Grigor'eva LV; Perekrest VV; Mikhaĭlov VV; Tereshkina NV; Dorokhina TV
    Vopr Virusol; 2002; 47(4):9-13. PubMed ID: 12271729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smallpox: vaccine reactions and contraindications.
    Tom WL; Kenner JR; Friedlander SF
    Dermatol Clin; 2004 Jul; 22(3):275-89, vi. PubMed ID: 15207309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative experimental studies of the combined use of vaccines, interferon and interferon inducers in neurovirus infections].
    Barinskiĭ IF; Shubladze AK; Fomina AN; Davydova AA; Bychkova EN
    Vopr Virusol; 1979; (3):262-7. PubMed ID: 223329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smallpox vaccination begins in U.S.--precautions needed.
    James JS
    AIDS Treat News; 2002 Dec; (386):2-4. PubMed ID: 12569873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon induction in monkeys by poly I-C complex with poly-L-lysine].
    Bektemirov TA; Burgasova MP; Andzhaparidze OG
    Vopr Virusol; 1976; (5):536-9. PubMed ID: 827121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral vaccination against smallpox (on the return of smallpox vaccination)].
    Vorob'ev AA; Podkuĭko VN; Maksimov VA
    Vestn Ross Akad Med Nauk; 2003; (1):5-10. PubMed ID: 12608077
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon induction via peroral administration of high-molecular polynucleotides].
    Grigorian SS; Ershov FI; Podgorodnichenko VK; Popov GA; Poverennyĭ AM
    Vopr Virusol; 1986; 31(3):338-42. PubMed ID: 2429452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.